Sunday, October 21, 2018

Xarelto - Injuries & Lawsuits

Xarelto News

Xarelto Fails to Prevent Clotting in Recent Trial

Johnson & Johnson’s and Bayer's recent attempt to expand the market for its controversial anticoagulant, Xarelto, encountered a setback when the medication failed to prevent clotting in high-risk patients during a recent clinical trial.Known as the MARINER Study, the trial involved approximately 12,000 patients who had been admitted to...

Xarelto Bleeding Risk “Low,” According To “Real-World” Data – Obtained From Research Funded By Bayer

A “real world” analysis of records on over 11,000 patients around the world who suffer from atrial fibrillation finds that risk of hemorrhaging and stroke associated with Xarelto (rivaroxaban) was similar or lower than what was seen during clinical trials. In a report published in the current issue of...

Xarelto Bleeding Risk “Low,” According to “Real-World” Data – Obtained From Research Funded by Bayer

A “real world” analysis of records on over 11,000 patients around the world who suffer from atrial fibrillation finds that risk of hemorrhaging and stroke associated with Xarelto (rivaroxaban) was similar or lower than what was seen during clinical trials. In a report published in the current issue of...

Xarelto and the Issue of Dietary Restrictions

One of the big selling points for the anticoagulant Xarelto (rivaroxaban) was the claim that, unlike warfarin, patients didn't have to worry so much about food interactions and what they ate while taking the medication. With warfarin, patients must avoid a number of healthful foods, particularly nutrient-rich leafy greens...

New Study Shows That Xarelto is No Better Than Aspirin for Preventing Secondary Stroke

A recent clinical study intended to demonstrate the superiority of Xarelto (rivaroxaban) to aspirin in the prevention of secondary stroke has been abandoned by its sponsors, Bayer and Johnson & Johnson.The study, known as NAVIGATOR-ESUS, involved 7,000 participants, but failed to give the drug makers the validation they...

Defendants Bayer and Johnson & Johnson Win Round 3 in Xarelto Litigation

Once again, a jury has sided with corporate defendants Bayer and Johnson & Johnson's Janssen division in a lawsuit alleging injuries due to the use of their blood-thinning medication Xarelto. This most recent verdict comes in the wake of two trials in which the jury found for the defendants.The...

Xarelto Injuries & Deaths Up By Over 40% in 2016

As the third lawsuit against Janssen Pharmaceuticals and Bayer AG gets underway, the Institute for Safe Medication Practices (ISMP) has released a disturbing report: the number of injuries and fatalities attributed to the anticoagulant medication Xarelto in 2016 was up by more than 40 percent over the previous year....

In The Face of Growing Litigation, Xarelto Makers Seek New Customers

Bayer Healthcare and Janssen Pharmaceuticals, manufacturers of the anti-coagulant Xarelto (rivaroxaban), currently face more than 15,000 lawsuits, alleging that they were aware of the risk of dangerous and even fatal bleed-outs and failed to inform the public as well as the medical community.Although there is at present no...
Xarelto Heart Study

Bayer and Janssen Call Off Clinical Trial for Xarelto – Apparently, They Don’t Think it’s Needed Anymore

The most recent clinical study of Xarelto (rivaroxaban) has been halted more than a year early, because Bayer AG, the drug's original developer and sponsor of the trial, is satisfied with the results. That study, known as “Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral...

Xarelto Lawsuits Pass the 15,000 Mark – Meanwhile, an Antidote is Still On Hold

As of mid-December 2016, Janssen Pharmaceuticals is facing more than 15,000 lawsuits (most of which have been consolidated into multidistrict litigation in Louisiana with approximately 1,000 scheduled in Pennsylvania) over its “new generation” anti-coagulant medication, Xarelto (riraroxaban).Federal trials will get underway in March of 2017, while state-level cases won't...
Xarelto Videos